Harvard Pilgrim Launching Closed Formulary, Weighing Specialty Drug Changes

Harvard Pilgrim Launching Closed Formulary, Weighing Specialty Drug Changes/ The mid-size payer’s move to a closed formulary represents a big change from years of offering relatively open formularies and comes as the insurer is feeling substantial pressure to control costs, Chief Medical Officer Michael Sherman explained in an interview. / “The Pink Sheet” DAILY November 13 2014 4:55 PM

Eisai Pans Germ